Vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor (ER) Degrader, Plus Abemaciclib in ER-Pos/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced or Metastatic Breast Cancer: TACTIVE-U Prelim Phase 1b Results

samuraciclib (CT7001) - Carrick Therap

Kisqali (ribociclib) - Novartis

Ibrance (palbociclib) - Pfizer

vepdegestrant (ARV-471) - Arvinas, Pfizer

Verzenio (abemaciclib) - Eli Lilly

fulvestrant - Generic mfg.

https://sabcs.org/Portals/0/Documents/Formatted_Abstracts%2011-27%20Without%20Embargoed.pdf?ver=qjVzk5LPNjOteEIvNEYJFw%3d%3d

John Hilton; Katarzyna J. Jerzak; A. Jo Chien; Jose L.M. Guimaraes; Colombe Chappey; Hechuan Wang; Stefanie K. Drescher; Elisa Dall'O'; Julia Perkins Smith; Swapnil Parmar; Rachel M. Layman; Cynthia Ma

Nov 2, 2024